Prof Michel Revel will be delivering the
Sixth Jakobovits Memorial Lecture
on Tuesday 28th November 2006
in the Gustave Tuck Lecture Theatre, University College London (Gower Street main entrance) at 8:00 p.m.
His topic will be: "Are genes our destiny?"
Prof Revel is one of Israel's most distinguished scientists, and science communicators. He was born in 1938 in Strasbourg, France, where he completed his medical studies and obtained a doctorate in biochemistry. In
1965 (with Prof. Gros) he discovered how protein synthesis is initiated, which controls the translation of genetic information. In 1968 he immigrated to Israel and joined the Weizmann Institute of Science, where he is Professor in Molecular Genetics. While at the Weizmann he has made fundamental contributions to research on interferon and its molecular mechanism of action. He is Chief Scientist at Interpharm and developed interferon beta for treatment of multiple sclerosis. His current work is on deriving oligodendrocytes from human embryonic stem cells and using them to repair myelin in multiple sclerosis. He is deeply involved in Bioethics, as chairman of Israel's National Bioethics Council, and as a member of the International Bioethics Committee of UNESCO. Prof. Revel received the Israel Prize in 1999 and the Emet Prize in 2004 for his contributions to medicine and biotechnology.